These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 22215890)

  • 1. Newer oral anticoagulants should be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation and risk factors for stroke or thromboembolism.
    Granger CB; Armaganijan LV
    Circulation; 2012 Jan; 125(1):159-64; discussion 164. PubMed ID: 22215890
    [No Abstract]   [Full Text] [Related]  

  • 2. New oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation.
    Ansell J
    Circulation; 2012 Jan; 125(1):165-70; discussion 170. PubMed ID: 22215891
    [No Abstract]   [Full Text] [Related]  

  • 3. Epidemiology, risk factors for stroke, and management of atrial fibrillation in China.
    Hu D; Sun Y
    J Am Coll Cardiol; 2008 Sep; 52(10):865-8. PubMed ID: 18755352
    [No Abstract]   [Full Text] [Related]  

  • 4. Canadian Cardiovascular Society atrial fibrillation guidelines 2010: prevention of stroke and systemic thromboembolism in atrial fibrillation and flutter.
    Cairns JA; Connolly S; McMurtry S; Stephenson M; Talajic M;
    Can J Cardiol; 2011; 27(1):74-90. PubMed ID: 21329865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Letter by christensen et Al regarding article, "new oral anticoagulants should not be used as first-line agents to prevent thromboembolism in patients with atrial fibrillation".
    Christensen TD; Hasenkam JM; Larsen TB
    Circulation; 2012 Jul; 126(4):e45; author reply e46. PubMed ID: 22825416
    [No Abstract]   [Full Text] [Related]  

  • 6. Female gender is a risk factor for stroke and thromboembolism in atrial fibrillation patients.
    Lane DA; Lip GY
    Thromb Haemost; 2009 May; 101(5):802-5. PubMed ID: 19404530
    [No Abstract]   [Full Text] [Related]  

  • 7. A promising advance in anticoagulant therapy for patients with atrial fibrillation.
    Olsson SB
    Ital Heart J; 2004 May; 5(5):335-9. PubMed ID: 15185895
    [No Abstract]   [Full Text] [Related]  

  • 8. [Oral anticoagulation for prevention of thromboembolism in non-rheumatic atrial fibrillation: indications, effectiveness and risk].
    Kottkamp H; Willems S; Hindricks G; Chen X; Haverkamp W; Hasfeld M; Borggrefe M; Breithardt G
    Z Kardiol; 1993 Nov; 82(11):667-73. PubMed ID: 8291287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic therapy in atrial fibrillation with ximelagatran: can it be an alternative to warfarin?].
    Selçuk H; Selçuk MT; Maden O
    Anadolu Kardiyol Derg; 2007 Mar; 7(1):54-8. PubMed ID: 17347079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent advances in oral anticoagulation for atrial fibrillation.
    Singh M; Adigopula S; Patel P; Kiran K; Khosla S
    Ther Adv Cardiovasc Dis; 2010 Dec; 4(6):395-407. PubMed ID: 20965952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation for atrial fibrillation: underuse?
    Pechlaner C
    Am J Med; 2011 Jul; 124(7):e11; author reply e13. PubMed ID: 21683818
    [No Abstract]   [Full Text] [Related]  

  • 12. [Even in 60-year-old atrial fibrillation is not uncommon. Advances in long-term treatment].
    Steinbeck G
    MMW Fortschr Med; 2006 Apr; 148(15):31. PubMed ID: 16711198
    [No Abstract]   [Full Text] [Related]  

  • 13. [Atrial fibrillation and thromboembolic events prevention. State of the art].
    Matteoli S; Trappolini M; Chillotti FM
    Minerva Cardioangiol; 2001 Feb; 49(1):1-13. PubMed ID: 11279381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Atrial fibrillation in dialysis patients].
    Vázquez Ruiz de Castroviejo E; Sánchez Perales MC
    Nefrologia; 2006; 26(1):16-24. PubMed ID: 16649422
    [No Abstract]   [Full Text] [Related]  

  • 15. Atrial fibrillation and stroke: are we looking in the right direction?
    Hatem SN; Cohen A
    Cardiovasc Res; 2022 Jan; 118(1):e4-e5. PubMed ID: 34897438
    [No Abstract]   [Full Text] [Related]  

  • 16. [Thromboembolism in non-rheumatic atrial fibrillation].
    Pengo V
    Haematologica; 2001 Sep; 86(9 Suppl):5-11. PubMed ID: 11759619
    [No Abstract]   [Full Text] [Related]  

  • 17. New oral anticoagulants in atrial fibrillation.
    Turpie AG
    Eur Heart J; 2008 Jan; 29(2):155-65. PubMed ID: 18096568
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Stroke with leg paralysis -- cardioversion in atrial fibrillation: prevention of thromboembolism in risk patients].
    MMW Fortschr Med; 2006 Jun; 148(23):58-9. PubMed ID: 16826742
    [No Abstract]   [Full Text] [Related]  

  • 19. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
    Hylek EM
    Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
    [No Abstract]   [Full Text] [Related]  

  • 20. Progress for stroke prevention with atrial fibrillation: emergence of alternative oral anticoagulants.
    Katsnelson M; Sacco RL; Moscucci M
    Circulation; 2012 Mar; 125(12):1577-83. PubMed ID: 22451607
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.